cysteine has been researched along with Antiphospholipid Syndrome in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, CH; Hsein, YC; Hsieh, SC; Hsu, PY; Ko, CL; Kuo, YM; Li, KJ; Lin, TS; Wu, CH; Wu, YW; Yen, RF | 1 |
| Atsumi, T; Gao, L; Giannakopoulos, B; Hogg, P; Koike, T; Krilis, SA; Moutsopoulos, HM; Qi, JC; Qi, M; Vlachoyiannopoulos, PG; Wong, JW; Yu, DM | 1 |
| Chen, JJ; Ho, ST; Kao, A; Shiau, YC; Wang, JJ | 1 |
| Kudo, S; Kuroda, Y; Matsui, M; Tokumaru, S; Uchino, A; Yoshikai, T | 1 |
4 other study(ies) available for cysteine and Antiphospholipid Syndrome
| Article | Year |
|---|---|
Increased heterogeneity of brain perfusion is an early marker of central nervous system involvement in antiphospholipid antibody carriers.
Topics: Adult; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Brain; Central Nervous System; Cerebrovascular Circulation; Cysteine; Female; Humans; Male; Mental Disorders; Middle Aged; Nervous System Diseases; Organotechnetium Compounds; Retrospective Studies; Thromboembolism; Tomography, Emission-Computed, Single-Photon | 2017 |
Factor XI is a substrate for oxidoreductases: enhanced activation of reduced FXI and its role in antiphospholipid syndrome thrombosis.
Topics: Adult; Aged; Antiphospholipid Syndrome; Blood Coagulation; Case-Control Studies; Cysteine; Disulfides; Enzyme-Linked Immunosorbent Assay; Factor XI; Factor XIa; Factor XIIa; Female; Humans; Male; Middle Aged; Oxidation-Reduction; Protein Disulfide-Isomerases; Thioredoxins; Thrombin; Thrombosis | 2012 |
Abnormal regional cerebral blood flow in primary antiphospholipid antibody syndrome patients with normal magnetic resonance imaging findings. A preliminary report.
Topics: Adult; Antiphospholipid Syndrome; Brain; Cerebrovascular Circulation; Cognition Disorders; Cysteine; Female; Humans; Magnetic Resonance Imaging; Middle Aged; Organotechnetium Compounds; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2002 |
Technetium-99m-ECD SPECT in antiphospholipid antibody syndrome: a drastic improvement in brain perfusion by antiplatelet therapy.
Topics: Antiphospholipid Syndrome; Aspirin; Cerebral Infarction; Cysteine; Female; Follow-Up Studies; Humans; Middle Aged; Organotechnetium Compounds; Tomography, Emission-Computed, Single-Photon; Treatment Outcome | 2001 |